Research & development

Infant Bacterial Therapeutics' most advanced clinical program is the IBP-9414 project developing a preventive treatment against necrotizing enterocolitis (NEC) and improvement of so-called feeding tolerance in premature infants.
Read more


NOVEMBER 7, 2019
Interim report January-Sept 2019, 08.00 CET

NOVEMBER 20-21, 2019
Jefferies 2019 London Healthcare Conference

NOVEMBER 25-26, 2019
Nordea Innovation Seminar, Stockholm
Read More